Check out my latest article: The Business Case for Shared Wet Lab Facilities in Toronto linkedin.com/pulse/business-… via @LinkedIn
Specific Biologics Inc. Announces Therapeutic Development Award from the Cystic Fibrosis Foundation prn.to/3IwEduu
Sam Ricchezza retweeted
News - Press Releases and Announcements - Detail - Rentschler Biopharma rentschler-biopharma.com/new…
Sam Ricchezza retweeted
Here's some coverage from the @AllogeneTx deal with new Canadian startup Notch Therapeutics, founded by @PZandstra and Juan Carlos Zúñiga-Pflücker bit.ly/2JWFPkh. Big congratulations again to everyone involved! #TMM2019
Sam Ricchezza retweeted
We Are Now Offering Three Grades of pDNA Vectors to Our Clients! Need pDNA vectors for your project? Is your project for pre-clinical, clinical or commercial? We’ve got you covered. hubs.ly/H0lsM4T0 or contact us at [email protected]
#pDNA #genetherapy #plasmidDNA
Sam Ricchezza retweeted
First-Ever OTC Inspections Drove Surge Of FDA Warning Letters In FY 2019 :: Pink Sheet pink.pharmaintelligence.info…
Sam Ricchezza retweeted
New @PBOAssoc e-newsletter, w/@PiramalPharma @CatalentPharma @ThermoFisherPR @LZLifeSciHealth @masybioservices @CobraBiologics @idtbiologika @samsungbiologi @RecipharmAB & more! Read/subscribe:
mailchi.mp/pharma-bio/pirama…
Sam Ricchezza retweeted
Member news: @CBiologics Introduces an Integrated Single-use Platform for Plasmid DNA (pDNA) Manufacture globenewswire.com/news-relea…
Sam Ricchezza retweeted
1/2 Congress is considering questions of Rx manufacturing, so let's get all our facts straight. According to @US_FDA data: 𝟔𝟎% of generic medicine doses come from outside the U.S., but only 𝟖.𝟓% from China and only 𝟐𝟒.𝟓% from India. The rhetoric just #DoesntAddUp
Sam Ricchezza retweeted
Halloween in the Village Saturday, Oct 26 from 11 to 2 pm. Bring your ghouls and Goblins by for a Halloween treat!
Capra's Kitchen had a pumpkin Carving Contest, please scroll thru our pumpkin Pictures and help us… instagram.com/p/B3u2bsthTfL/…
Sam Ricchezza retweeted
FDA issues draft guidance on DMFs (PDF): fda.gov/media/131861/downloa…
Sam Ricchezza retweeted
8 days until the 3rd annual @PBOAssoc Meeting & Conference: The only conference built for CMO/CDMOs! pharma-bio.org/conference
Sam Ricchezza retweeted
#Vaccine #investment breathing new life into space? biopharma-reporter.com/Artic… via @benhargreaves08 @BioPharmaReport. And this is a lot of what @BiologicsforAll is looking to address. Reduce cost, footprint and implementation to make vaccines accessible.
This is a great networking event hosted by @contractpharma for connecting with pharma industry professionals. If you haven't registered, there is still time. See you there!
Join us next week for the pharma event of the year. Discuss all of the aspects of contract manufacturing with experienced professionals. #ContractPharma2019 #ContractPharma
Sam Ricchezza retweeted
"Ontario's reputation as a world-leading centre of activity in #stemcell research is growing even stronger" via @clinicaltrialON bit.ly/2kJkaTf
Sam Ricchezza retweeted
LATimes - ‘It’s not working': An FDA insider’s view of where medical innovation falls short - by Emily Baumgaertner latimes.com/science/story/20…
Sam Ricchezza retweeted
We can't produce #celltherapy #genetherapy without #viralvectors & there is a global shortage. The newly funded iVexSol consortium, with CCRM @GE_LifeSciences @GEHealthcare @STEMCELLTech & funded by @NGen_Canada @ISED_CA will use an advanced tech to deliver these reagents






















